Skip to content
#explainable ai Review Open access

Melanoma Prognostication Using AI‐Guided Histopathology

Sep 2026 · International Journal of Dermatology · Vol 65, pp. S46 - S51 · 2 citations · 39 references
Medicine

TL;DR

This review examines how computational pathology and convolutional neural networks (CNNs) can improve histopathologic diagnosis and risk stratification of melanoma, evaluate current image-based deep learning (DL) approaches, and outline a path toward explainable, multimodal prognostic tools.

Abstract

Accurate diagnosis and risk stratification are central for optimal management of patients with melanoma. Current American Joint Committee on Cancer (AJCC) staging systems inadequately stratify patients with clinically meaningful metastatic potential. Manual histopathologic interpretation compounds this limitation, particularly for diagnostically ambiguous lesions at the benign‐malignant interface, where concordance is highly variable. This review examines how computational pathology and convolutional neural networks (CNNs) can improve histopathologic diagnosis and risk stratification of melanoma, evaluate current image‐based deep learning (DL) approaches, and outline a path toward explainable, multimodal prognostic tools. We review published DL models applied to hematoxylin and eosin whole‐slide images (H&E WSIs) for melanoma diagnosis, subtype classification, and survival prediction, and discuss integration with transcriptomic and spatial proteomic data modalities. Computational pathology, informed by deep learning, can reliably identify melanomas at risk of disease recurrence and progression. These inferences can be enhanced by integration of spatial molecular profiling, which can also provide mechanistic explainability to the H&E‐based DL models. However, limitations in dataset diversity, external validation, model interpretability, and generalizability across populations and image acquisition protocols currently prevent clinical adoption. Outcome‐anchored, multimodal computational pathology pipelines integrating H&E WSIs with spatial multi‐omic profiling offer a biologically grounded and scalable framework for personalized risk stratification in stage I‐III CM, with potential to standardize diagnosis, discover novel prognostic features, and inform individualized treatment strategies.

Read PDF

Similar papers

Open access Aug 2026

High-quality annotated histopathological skin melanoma subtype slides for AI model development and validation

Cutaneous melanoma (CM) is a highly aggressive form of skin cancer requiring accurate subtype classification for effective prognosis and treatment. To address the scarcity of high-quality datasets, we curated 82 Hematoxylin & Eosin (H&E)-stained whole slide images (WSIs) from 32 patients in the Clinical Proteomic Tum...

Seongho Yoon, Byungeun Shon, So-yeon Kim et al. · 0 citations
Open access Sep 2026

Deep Learning Classification of Uveal Melanoma and Metastatic Carcinoma on Cytology Specimens: A Single-Center Experience

Purpose Differentiating between a choroidal melanoma and metastatic carcinoma to the choroid on cytological specimens presents significant diagnostic challenges due to subtle morphological differences in the sparse cells available in the sample and the increasing scarcity of specialist ocular pathologists. This study d...

Maxine Jackson, H. Kalirai, Rumana N. Hussain et al. · 0 citations
Open access Sep 2026

Melanoma Intelligence: Explainable AI Reveals Histopathologic Aggressiveness as the Dominant Axis of Lymph-Node Metastasis

Background/Objectives: Lymph-node metastasis remains central to staging, prognosis, surveillance, and treatment planning in malignant melanoma. At present, most statistical models assessing nodal metastatic risk in malignant melanoma consider pathological descriptors, inflammatory markers, metabolic alterations, clinic...

V. Atanasescu, V. Grigorean, R. Tulin et al. · 0 citations

Related blog posts

Google DeepMind Blog Nov 18, 2026

Genie 4 is now available

We are rolling out a new Project Genie experience to eligible Google AI Ultra subscribers, opening access to our new Genie 4 world model.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.